Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11858941 Heterocyclic and heteroaryl compounds for treating Huntington's disease

Patent 11858941 was granted and assigned to PTC Therapeutics, Inc. on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 4 Jan, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 4 Jan, 2024
Edits made to:
Infobox (+47 properties)
‌

 US Patent 11858941 Heterocyclic and heteroaryl compounds for treating Huntington's disease

Infobox
Is a
Patent
Patent
0
Patent Applicant
PTC Therapeutics, Inc.
PTC Therapeutics, Inc.
0
Current Assignee
PTC Therapeutics, Inc.
PTC Therapeutics, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118589410
Patent Inventor Names
Aleksey I. Gerasyuto0
Andrew J. Kassick0
Anthony R. Mazzotti0
Anthony Turpoff0
Anuradha Bhattacharyya0
Gary Mitchell Karp0
Guangming Chen0
Jana Narasimhan0
Jigar Patel0
Matthew G. Woll0
Md Rauful Alam0
Michael A. Arnold0
Nadiya Sydorenko0
Nanjing Zhang0
Suresh Babu0
Wuming Yan0
Young-Choon Moon0
Date of Patent
January 2, 2024
0
Patent Application Number
172546600
Date Filed
June 25, 2019
0
Patent Citations
‌
US Patent 7326711 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
0
‌
US Patent 7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
0
‌
US Patent 7473784 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
0
‌
US Patent 7569337 Coumarines useful as biomarkers
0
‌
US Patent 7655657 Fused bicycloheterocycle substituted quinuclidine derivatives
0
‌
US Patent 7897792 Coumarin derivative having antitumor activity
0
‌
US Patent 7910578 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use
0
‌
US Patent 8143274 1-(2H)-isoquinolone derivative
0
‌
US Patent 8314119 Azaadamantane derivatives and methods of use
0
‌
US Patent 8337941 Fluorescent substrates for monoamine transporters as optical false neurotransmitters
0
‌
US Patent 8563550 Imidazolothiadiazoles for use as protein kinase inhibitors
0
‌
US Patent 8633019 Methods for treating spinal muscular atrophy
0
‌
US Patent 8846661 Diazahomoadamantane derivatives and methods of use thereof
0
‌
US Patent 8921361 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
0
‌
US Patent 9371336 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9399649 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9617268 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9969754 Compounds for treating spinal muscular atrophy
0
‌
US Patent 6977255 Therapeutic morpholino-substituted compounds
0
Patent Primary Examiner
‌
Susanna Moore
0
CPC Code
‌
C07D 519/00
0
‌
C07D 487/04
0

Find more entities like US Patent 11858941 Heterocyclic and heteroaryl compounds for treating Huntington's disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo